Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F5W3E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,046
Award facts
- Contract value 100% obligated
- $10,046.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,046.44 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 ml pen injections (0.5 ml units) with an ultimate completion date of January 30, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion vehicle running through December 31, 2031, which serves as the primary procurement mechanism for pharmaceutical and medical supply deliveries supporting military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, regularly supplies critical medications and medical commodities to federal agencies through its extensive portfolio of federal contracts. The company's delivery orders under the DLA IDC encompass a broad spectrum of pharmaceutical products across multiple therapeutic domains, from specialty medications and vaccines to brand-name and generic drugs, supporting military treatment facilities and veterans' healthcare programs worldwide. This particular delivery order for Zepbound, a diabetes medication, reflects the company's ongoing role as a key vendor in the federal medical supply chain for defense healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F5W3E?
SPE2DR26F5W3E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26F5W3E worth?
The government has obligated $10,046 on SPE2DR26F5W3E.
Is contract SPE2DR26F5W3E an order under another contract?
Yes. SPE2DR26F5W3E is a delivery order under SPE2DR25D3404, an indefinite delivery contract.
Was contract SPE2DR26F5W3E competed?
The extent of competition for SPE2DR26F5W3E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award